![]() Editas Medicine Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics. | ![]() Caribou Biosciences Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company. | |
Founding Date | Founding Date 2013 | Founding Date 2012 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Cambridge, US HQ Boulder, US Cambridge, US | Locations Berkeley, US HQ |
Employees | Employees 20816% increase | Employees 1477% decrease |
Valuation ($) | Valuation ($) 256.5 m | Valuation ($) 174.4 m |
Financial | ||
Revenue (est.) | Revenue (est.) $40.5m (FY, 2025) | Revenue (est.) $11.2m (FY, 2025) |
Net income | Net income ($160.1m) (FY, 2025) | Net income ($148.1m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 210m | Total funding raised $ 159.5m |

Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company.
View company